Navigation Links
Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
Date:7/21/2009

MOUNTAIN VIEW, Calif., July 21 /PRNewswire/ -- Howard Rosenberg, M.D., a board-certified plastic surgeon and Medical Director at Accent on Aesthetics Plastic Surgery Medical Center, has selected Artefill, the first and only FDA-approved microsphere-enhanced collagen filler for the correction of smile lines. Dr. Rosenberg has treated more than fifty patients with Artefill due to its proven success and effectiveness for the long lasting correction of wrinkles.

Dr. Rosenberg commented, "Artefill is a product we have consistently recommended to our patients who are looking for a dermal filler that lasts longer and doesn't require repeat injections. We believe we have had great success with the product over the past few years as it's easy to administer and the patient experience is similar to temporary fillers on the market today."

This simple, in-office procedure takes approximately fifteen minutes to complete. A patient is injected with Artefill similar to other dermal fillers with the key difference being its lasting effect. The unique microspheres in Artefill are not absorbed by the body and therefore provide the support the skin needs for long lasting natural feeling results. This is different from temporary dermal fillers that are made of different kinds of natural or synthetic materials that are completely absorbed by the body over time and require repeat injections to maintain wrinkle correction. A skin test is required prior to treatment or approximately four (4) weeks ahead of time, to ensure a patient is not allergic to the collagen or anesthetic in Artefill.

Artefill is only offered by a select group of physicians in Northern California and is not available at all physician offices. Dr. Rosenberg is one of the company trained and select few company sponsored physicians who has the skills and experience needed to administer the produc
'/>"/>

SOURCE Accent on Aesthetics Plastic Surgery Medical Center
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Accepts sNDA for Alternative Dosing Regimen for Dacogen(R) (decitabine for injection) to Treat Patients with Myelodysplastic Syndromes (MDS)
2. New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults
3. Plastic Surgeons Warn of Malnutrition in Body Contouring Patients
4. Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
5. SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
6. Vion Pharmaceuticals Announces Presentation of Data of Cloretazine(R) (VNP40101M) in Elderly Patients with High-Risk Myelodysplastic Syndromes at the EHA Annual Meeting
7. Got Fat?: Plastic Surgeons Review Fat-Melting and Fat-Grafting Procedures
8. Miami Plastic Surgeon Offers Hope to Acne Scarred Patients
9. Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)
10. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
11. Shoulder Surgery Doesnt Prevent Return to Sports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... BETHESDA, Md. , Jan. 23, 2015  Northwest Biotherapeutics, Inc. ... developing DCVax® personalized immune therapies for operable and inoperable solid ... will present at the 7 th Annual Phacilitate Immunotherapy ... NW Bio,s presentation at Phacilitate will take place on January ...
(Date:1/23/2015)... ATLANTA , Jan. 23, 2015 More than a ... a quarter of those with private insurance, filled a prescription ... to a report in this week,s Morbidity and Mortality Weekly ... health care providers to treat moderate to severe pain.  They ...
(Date:1/23/2015)... Feffer LLP ( www.hfesq.com ) is investigating potential claims ... or the "Company") (NASDAQ: ADXS ), concerning ... shareholders. On January 21, 2015, an article ... had misrepresented the clinical data for its ADXS-HPV drug ...
Breaking Medicine Technology:NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2
... 14, 2011 Regulus Therapeutics Inc ., a ... medicines targeting microRNAs, today announced that it has added ... The addition of Dr. Hannon, a researcher whose work ... microRNA pathway, increases SAB membership to six pioneers in ...
... Renal Therapies Division of B. Braun Medical ... Plasmat™ Futura System for H.E.L.P. ®   LDL Apheresis ... therapy provides a more easy-to-use system for clinicians ... severe hypercholesterolemia. (Logo: http://photos.prnewswire.com/prnh/20081022/NYW008LOGO) ...
Cached Medicine Technology:Regulus Therapeutics Appoints Gregory Hannon, Ph.D. to Scientific Advisory Board 2Regulus Therapeutics Appoints Gregory Hannon, Ph.D. to Scientific Advisory Board 3Regulus Therapeutics Appoints Gregory Hannon, Ph.D. to Scientific Advisory Board 4Regulus Therapeutics Appoints Gregory Hannon, Ph.D. to Scientific Advisory Board 5B. Braun Renal Therapies Division Announces Availability of Advanced Apheresis Therapy System 2
(Date:1/22/2015)... Deer Path of Huntley -- a BMA affordable ... from 3 p.m. to 4 p.m. on Feb. 13. , The ... serves adults with physical disabilities between the ages of 22 and ... games and sweetheart-themed karaoke. , For more information about the event ...
(Date:1/22/2015)... LunaDress, with its top dressmaking technologies, has been a ... is showing its latest designs of wedding dresses and launching ... company’s CEO, all the fresh new products are designed for ... to 80% off. All the clothes from LunaDress follow up ...
(Date:1/22/2015)... 22, 2015 Gabe’s Chemo Duck Program is pleased ... first app ever created for kids with cancer. The Chemo Duck ... devices, is filled with enjoyable games to help children of all ... free app helps to keep kids entertained, educated and at ease ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 The Incredible Bulk ... Ben Pakulski to increase lean muscle by up to 30lbs ... caught the attention of HealthyandFitZone.com’s Stan Stevenson, prompting an investigative ... it is a step-by-step, scientific diet formula that allows the ...
(Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, has recently ... View website of AngelWeddingDress.com to find more details. ... online for a bridal party. AngelWeddingDress offers a variety ... Its maternity wedding dresses are specially designed for 2015. ...
Breaking Medicine News(10 mins):Health News:Deer Path of Huntley Affordable Assisted Living to Host Valentine's Day Happy Hour 2Health News:LunaDress Shows The Latest Styles Of Wedding Dresses In 2015 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2
... food is better than any medication. Foods which are rich in ... ,195 healthy girls aged 10 to 12 were studied, their calcium ... of girls in 1,000 mg calcium tablets, 1000 mg calcium plus ... of calcium or placebo tablets was made by Dr. Sulin Cheng ...
... Wake Forest University Baptist Medical Center shows that patient trust ... law to legalize physician-assisted // death were to be enforced ... on the results of a telephonic survey conducted among a ... was designed to measure attitudes about physician aid in dying. ...
... deigned for slow release of medication are found to be ... study conducted on stents used for cardiac bypass // . ... scar tissue, thereby reducing incidence of restenosis (re-narrowing), heart attack ... a grafted vein or into a native coronary artery during ...
... study has found that young people who survive natural ... at a high risk of developing// chronic post-traumatic stress ... study conducted by UCLA researchers says that these factors ... post-disaster. The study highlights the case of young survivors ...
... of India Anbumoni Ramdoss justified the increase in the fees ... of Medical Sciences //(AIIMS), saying that this was necessary to ... first time that a hike is taking place at the ... Rs. 420 crores while the revenue generated by it is ...
... seven North Eastern States of India have taken a pledge ... AIDS Day was marked by marches in the states of ... HIV positive people, health workers, schoolchildren, and rehabilitated drug addicts. ... large number of drug addicts. ,'The slogan this ...
Cached Medicine News:Health News:Drug-Eluting Stents Ensure Patency Of The Saphenous Vein Grafts 2Health News:India Marks World AIDS Day 2
The Clinac 6EX accelerator is a cost-effective choice. Configured for the latest treatment techniques, the Clinac 6EX has the tightest mechanical and dosimetric specifications for any single-energy m...
Based on the clinically proven ACS MULTI-LINK Stent, ULTRA is a coronary stent system specifically designed for use in larger vessels. This innovative system utilizes a unique stent pattern to give y...
The MULTI-LINK RX PENTA Coronary Stent Systems with new ACCESS-LINK Stent Design are indicated for improving coronary luminal diameter....
Take Performance to a Higher Level....
Medicine Products: